Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer.

Clinical trial NCT03283384 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03283384
Sponsor: Borstkanker Onderzoek Groep
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2019-06-15
Primary completion: 2022-12-06
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.